ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 86371 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 86371; 2) Community: the network communities that were significantly associated with the response to NSC 86371; 3) Molecule: the relationships between components within communities and NSC 86371; 4) MDR: the compounds that were significantly associated with the NSC 86371.

NSC Compound Enrichment Correlation
NSC 18805 .gamma.-Thujaplicine 0.0114553853234977 0.26808174
NSC 263434 N,N'-Bis(3-methoxy-9-acridinyl)-1,8-octanediamine 0.0114553853234977 0.1560417
NSC 335995 Null 0.0114553853234977 0.23711693
NSC 339137 PHYSALOLACTONE 0.0114553853234977 0.400801
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0114553853234977 0.39005115
NSC 354974 Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0114553853234977 0.36909287
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.0114553853234977 0.25609309
NSC 47468 Null 0.0114553853234977 0.40718078
NSC 603578 Platinum, tetrachloro[dimethylsilylenebis(methanamine)]-, (OC-6-22) 0.0114553853234977 0.4349186
NSC 606497 Camptothecin Derivative 0.0114553853234977 0.27304528
Total:139  Current:48    [First] [Prev] [Next] [Last]